{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:21:19Z","timestamp":1790234479313,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.imlet.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T12:30:36Z","timestamp":1479558636000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["IL-6 roles \u2013 Molecular pathway and clinical implication in pancreatic cancer \u2013 A systemic review"],"prefix":"10.1016","volume":"181","author":[{"given":"Vlad-Vasile","family":"Pop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrada","family":"Seicean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Lupan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Samasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia-Cristina","family":"Burz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.imlet.2016.11.010_bib0005","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1002\/cncr.28863","article-title":"Australian pancreatic cancer genome, clinical and pathologic features of familial pancreatic cancer","volume":"120","author":"Humphris","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.imlet.2016.11.010_bib0010","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.2147\/OTT.S103581","article-title":"Interleukin-32alpha inactivates JAK2\/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells","volume":"9","author":"Chen","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"Suppl. 5","key":"10.1016\/j.imlet.2016.11.010_bib0015","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2016.11.010_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1499-3872(14)60259-9","article-title":"Interleukin-6: a villain in the drama of pancreatic cancer development and progression","volume":"13","author":"Holmer","year":"2014","journal-title":"Hepat. Pancreat. Dis. Int.: HBPD INT"},{"issue":"5","key":"10.1016\/j.imlet.2016.11.010_bib0025","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/MPA.0b013e31823cdd10","article-title":"IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines","volume":"41","author":"Block","year":"2012","journal-title":"Pancreas"},{"issue":"Pt. 2","key":"10.1016\/j.imlet.2016.11.010_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.imlet.2016.11.010_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/hpb.12002","article-title":"Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil","volume":"15","author":"Arshad","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11011-011-9270-x","article-title":"High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line","volume":"27","author":"Li","year":"2012","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.imlet.2016.11.010_bib0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10620-008-0390-z","article-title":"Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis","volume":"54","author":"Talar-Wojnarowska","year":"2009","journal-title":"Dig. Dis. Sci."},{"issue":"17","key":"10.1016\/j.imlet.2016.11.010_bib0050","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1111\/febs.12338","article-title":"Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?","volume":"280","author":"Munoz-Canoves","year":"2013","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.smim.2014.01.002","article-title":"Interleukin-6 in inflammatory and malignant diseases of the pancreas","volume":"26","author":"Lesina","year":"2014","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2016.11.010_bib0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1947601910383417","article-title":"Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer","volume":"1","author":"Okitsu","year":"2010","journal-title":"Genes Cancer"},{"issue":"7","key":"10.1016\/j.imlet.2016.11.010_bib0065","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4161\/cbt.6.7.4328","article-title":"IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells","volume":"6","author":"Feurino","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"Pt. 1","key":"10.1016\/j.imlet.2016.11.010_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J"},{"issue":"2","key":"10.1016\/j.imlet.2016.11.010_bib0075","first-page":"415","article-title":"Stress-associated hormone, norepinephrine, increases proliferation and IL-6 levels of human pancreatic duct epithelial cells and can be inhibited by the dietary agent, sulforaphane","volume":"33","author":"Chan","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.imlet.2016.11.010_bib0080","article-title":"Relationship between inflammation and cancer progression: recent advances in interleukin-6 signaling and its blockage in cancer therapy","volume":"1","author":"Nagasaki","year":"2014","journal-title":"Recept. Clin. Investig."},{"issue":"4","key":"10.1016\/j.imlet.2016.11.010_bib0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.imlet.2016.11.010_bib0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.cr.7310027","article-title":"Regulation of cytokine signaling pathways by PIAS proteins","volume":"16","author":"Shuai","year":"2006","journal-title":"Cell Res."},{"issue":"Suppl","key":"10.1016\/j.imlet.2016.11.010_bib0095","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokine signaling in 2002: new surprises in the Jak\/Stat pathway","volume":"109","author":"O\u2019Shea","year":"2002","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.imlet.2016.11.010_bib0100","first-page":"183","article-title":"Proinflammatory cytokines: an insight into pancreatic oncogenesis","volume":"69","author":"Miron","year":"2010","journal-title":"Roum. Arch. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2016.11.010_bib0105","first-page":"881","article-title":"Cytokine regulation of constitutive production of interleukin-8 and \u22126 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer","volume":"21","author":"Wigmore","year":"2002","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.imlet.2016.11.010_bib0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4149\/neo_2011_05_396","article-title":"The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro","volume":"58","author":"Huang","year":"2011","journal-title":"Neoplasma"},{"issue":"7","key":"10.1016\/j.imlet.2016.11.010_bib0115","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/carcin\/bgr075","article-title":"Mesothelin overexpression promotes autocrine IL-6\/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation","volume":"32","author":"Bharadwaj","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.imlet.2016.11.010_bib0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1476-4598-10-106","article-title":"Mesothelin confers pancreatic cancer cell resistance to TNF-alpha-induced apoptosis through Akt\/PI3K\/NF-kappaB activation and IL-6\/Mcl-1 overexpression","volume":"10","author":"Bharadwaj","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.imlet.2016.11.010_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-016-0301-7","article-title":"Transcriptional repression of SOCS3 mediated by IL-6\/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis","volume":"35","author":"Huang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13046-016-0406-z","article-title":"PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value","volume":"35","author":"Xu","year":"2016","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/carcin\/bgu233","article-title":"STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells","volume":"36","author":"Fofaria","year":"2015","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis\u2013correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"4A","key":"10.1016\/j.imlet.2016.11.010_bib0145","first-page":"2449","article-title":"Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells","volume":"21","author":"Miyamoto","year":"2001","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2015.03.014","article-title":"REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: involvement of a REG3A-JAK2\/STAT3 positive feedback loop","volume":"362","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.imlet.2016.11.010_bib0155","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1078-0432.CCR-09-2405","article-title":"ZIP4 regulates pancreatic cancer cell growth by activating IL-6\/STAT3 pathway through zinc finger transcription factor CREB","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.imlet.2016.11.010_bib0160","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4161\/auto.20258","article-title":"AGER\/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway","volume":"8","author":"Kang","year":"2012","journal-title":"Autophagy"},{"issue":"20","key":"10.1016\/j.imlet.2016.11.010_bib0165","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1093\/nar\/gkp723","article-title":"MeCP2\/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines","volume":"37","author":"Dandrea","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.imlet.2016.11.010_bib0170","doi-asserted-by":"crossref","first-page":"e24891","DOI":"10.4161\/onci.24891","article-title":"Pancreatic cancer-associated stellate cells: a viable target for reducing immunosuppression in the tumor microenvironment","volume":"2","author":"Mace","year":"2013","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.imlet.2016.11.010_bib0175","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.imlet.2016.11.010_bib0180","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","article-title":"Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.imlet.2016.11.010_bib0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/icb.2014.22","article-title":"Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion","volume":"92","author":"Karnevi","year":"2014","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cyto.2015.04.006","article-title":"Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines","volume":"75","author":"Bassaganas","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.imlet.2016.11.010_bib0195","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MPA.0000000000000335","article-title":"Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels","volume":"44","author":"Miura","year":"2015","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.imlet.2016.11.010_bib0200","doi-asserted-by":"crossref","first-page":"e113259","DOI":"10.1371\/journal.pone.0113259","article-title":"Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer","volume":"9","author":"Fujiwara","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.imlet.2016.11.010_bib0205","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.imlet.2016.11.010_bib0210","first-page":"363","article-title":"Liver macrophages contribute to pancreatic cancer-related cachexia","volume":"21","author":"Martignoni","year":"2009","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.imlet.2016.11.010_bib0215","first-page":"113","article-title":"Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer","volume":"38","author":"Zhang","year":"2008","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.imlet.2016.11.010_bib0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-29-51","article-title":"Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro","volume":"29","author":"Huang","year":"2010","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","article-title":"Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression","volume":"49","author":"Maes","year":"1993","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.imlet.2016.11.010_bib0230","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","article-title":"Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings","volume":"158","author":"Musselman","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"39","key":"10.1016\/j.imlet.2016.11.010_bib0235","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.3748\/wjg.v21.i39.11168","article-title":"Prognostic significance of plasma interleukin-6\/-8 in pancreatic cancer patients receiving chemoimmunotherapy","volume":"21","author":"Tsukinaga","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.imlet.2016.11.010_bib0240","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/MPA.0b013e3182546e13","article-title":"An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma","volume":"41","author":"Dima","year":"2012","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.imlet.2016.11.010_bib0245","first-page":"1091","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival","volume":"21","author":"Moses","year":"2009","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.imlet.2016.11.010_bib0250","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jcla.20395","article-title":"Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis","volume":"24","author":"Mroczko","year":"2010","journal-title":"J. Clin. Lab. Anal."},{"issue":"12","key":"10.1016\/j.imlet.2016.11.010_bib0255","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/cncr.20672","article-title":"Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis","volume":"101","author":"Ebrahimi","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.imlet.2016.11.010_bib0260","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00262-005-0047-0","article-title":"Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival","volume":"55","author":"Bellone","year":"2006","journal-title":"Cancer Immunol. Immunother.: CII"},{"issue":"5","key":"10.1016\/j.imlet.2016.11.010_bib0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11605-013-2168-7","article-title":"Activation of the IL-6R\/Jak\/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma","volume":"17","author":"Denley","year":"2013","journal-title":"J. Gastrointest. Surg."},{"issue":"39","key":"10.1016\/j.imlet.2016.11.010_bib0270","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.3748\/wjg.v21.i39.11168","article-title":"Prognostic significance of plasma interleukin-6\/-8 in pancreatic cancer patients receiving chemoimmunotherapy","volume":"21","author":"Tsukinaga","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.imlet.2016.11.010_bib0275","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/bjc.2013.174","article-title":"Serum levels of IL-6 and IL-1\u03b2 can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer","volume":"108","author":"Mitsunaga","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.imlet.2016.11.010_bib0280","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ijc.29445","article-title":"Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer","volume":"137","author":"Goumas","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.imlet.2016.11.010_bib0285","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/mol.114.096529","article-title":"Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion","volume":"87","author":"Lui","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.imlet.2016.11.010_bib0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.canlet.2014.08.011","article-title":"Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells","volume":"354","author":"Peng","year":"2014","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.imlet.2016.11.010_bib0295","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-07-1104","volume":"13","author":"Lang","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0300","first-page":"44","article-title":"In vitro protective effect of celergen, a bioactive marine compound, on interleukin-6-related invasiveness of pancreatic cancer","volume":"85","author":"Catanzaro","year":"2014","journal-title":"Acta Bio-med.: Atenei Parm."},{"issue":"12","key":"10.1016\/j.imlet.2016.11.010_bib0305","doi-asserted-by":"crossref","first-page":"e50165","DOI":"10.1371\/journal.pone.0050165","article-title":"Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2016.11.010_bib0310","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2147\/OTT.S91511","article-title":"Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial\u2013mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells","author":"Huang","year":"2015","journal-title":"OTT"},{"issue":"1","key":"10.1016\/j.imlet.2016.11.010_bib0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2013.12.006","article-title":"Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells","volume":"345","author":"Guan","year":"2014","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.imlet.2016.11.010_bib0320","doi-asserted-by":"crossref","first-page":"e70334","DOI":"10.1371\/journal.pone.0070334","article-title":"Targeting cancer-related inflammation: chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.imlet.2016.11.010_bib0325","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3736\/jcim20100709","article-title":"Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors","volume":"8","author":"Ouyang","year":"2010","journal-title":"Zhong Xi Yi Jie He Xue Bao=J. Chin. Integr. Med."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816302930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816302930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T01:42:22Z","timestamp":1657762942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247816302930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":65,"alternative-id":["S0165247816302930"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2016.11.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 roles \u2013 Molecular pathway and clinical implication in pancreatic cancer \u2013 A systemic review","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}